Purpose

A soy isoflavone based product that helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D.

Each Capsule Contains

200 mg of the extract contains 50 mg of soy isoflavone aglycone equivalents or 80 mg of soy isoflavones (aglycones plus the glycoside derivatives).

The soy isoflavone aglycones are:

• Genistein equivalents: 27.7 mg
• Daidzein equivalents: 17.2 mg
• Glycitein equivalents: 5.1 mg

Encapsulated in vegetable capsules

Recommended Dosage

Preparations equivalent to 75-125 mg aglycone isoflavone equivalent (AIE) from genistein/genistin compounds per day.

Recommended Use

One capsule per time, twice per day and preferably with a meal.

Direction for Use

Take a few hours before or after taking medications or health care products.

Duration(s) of Use

Use for a minimum of 6 months to see beneficial effects. Consult a health care practitioner for use beyond one year.

Cautions and Warnings

• Ensure you are up-up-to date on mammograms and gynaecological evaluations prior to use.
• Consult a health care practitioner prior to use if you are taking blood thinners.
• Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological diseases, including ovarian endometriosis, and or uterine fibroids.
• Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine).
• Consult a health care practitioner prior to use if you are taking hormone replacement therapy (HRP) including thyroid hormone replacement therapy.
• Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness, or if you experience a recurrence of menstruation and/or uterine spotting.
• Keep out of reach of children.
• Do not if allergic to soy.

Contra-indications

Do not use if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.

Natural Product Number (NPN #80023124)

Bone Health is authorized for sale by Health Canada.

Reference: Health Canada, Soybean Extracts and Isolates Monograph, October 29, 2009 (Google Search).